Literature DB >> 28985210

Engineering MeCP2 to spy on its targets.

Patricia M Horvath1, Lisa M Monteggia1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2017        PMID： 28985210     DOI： 10.1038/nm.4425

Source DB:  PubMed          Journal:  Nat Med        ISSN： 1078-8956            Impact factor:   53.440


× No keyword cloud information.
  12 in total

Review 1.  Rett syndrome and the impact of MeCP2 associated transcriptional mechanisms on neurotransmission.

Authors:  Lisa M Monteggia; Ege T Kavalali
Journal:  Biol Psychiatry       Date:  2008-12-05       Impact factor: 13.382

2.  Transcriptional repression by the methyl-CpG-binding protein MeCP2 involves a histone deacetylase complex.

Authors:  X Nan; H H Ng; C A Johnson; C D Laherty; B M Turner; R N Eisenman; A Bird
Journal:  Nature       Date:  1998-05-28       Impact factor: 49.962

3.  Rett syndrome is caused by mutations in X-linked MECP2, encoding methyl-CpG-binding protein 2.

Authors:  R E Amir; I B Van den Veyver; M Wan; C Q Tran; U Francke; H Y Zoghbi
Journal:  Nat Genet       Date:  1999-10       Impact factor: 38.330

4.  Methyl-CpG-binding protein 2 (MECP2) mutation type is associated with disease severity in Rett syndrome.

Authors:  Vishnu Anand Cuddapah; Rajesh B Pillai; Kiran V Shekar; Jane B Lane; Kathleen J Motil; Steven A Skinner; Daniel Charles Tarquinio; Daniel G Glaze; Gerald McGwin; Walter E Kaufmann; Alan K Percy; Jeffrey L Neul; Michelle L Olsen
Journal:  J Med Genet       Date:  2014-01-07       Impact factor: 6.318

5.  Transcriptional profiling of a mouse model for Rett syndrome reveals subtle transcriptional changes in the brain.

Authors:  Matthew Tudor; Schahram Akbarian; Richard Z Chen; Rudolf Jaenisch
Journal:  Proc Natl Acad Sci U S A       Date:  2002-11-13       Impact factor: 11.205

6.  MeCP2-dependent transcriptional repression regulates excitatory neurotransmission.

Authors:  Erika D Nelson; Ege T Kavalali; Lisa M Monteggia
Journal:  Curr Biol       Date:  2006-04-04       Impact factor: 10.834

7.  A progressive syndrome of autism, dementia, ataxia, and loss of purposeful hand use in girls: Rett's syndrome: report of 35 cases.

Authors:  B Hagberg; J Aicardi; K Dias; O Ramos
Journal:  Ann Neurol       Date:  1983-10       Impact factor: 10.422

8.  Biotin tagging of MeCP2 in mice reveals contextual insights into the Rett syndrome transcriptome.

Authors:  Brian S Johnson; Ying-Tao Zhao; Maria Fasolino; Janine M Lamonica; Yoon Jung Kim; George Georgakilas; Kathleen H Wood; Daniel Bu; Yue Cui; Darren Goffin; Golnaz Vahedi; Tae Hoon Kim; Zhaolan Zhou
Journal:  Nat Med       Date:  2017-09-18       Impact factor: 53.440

9.  MeCP2, a key contributor to neurological disease, activates and represses transcription.

Authors:  Maria Chahrour; Sung Yun Jung; Chad Shaw; Xiaobo Zhou; Stephen T C Wong; Jun Qin; Huda Y Zoghbi
Journal:  Science       Date:  2008-05-30       Impact factor: 47.728

10.  Disruption of DNA-methylation-dependent long gene repression in Rett syndrome.

Authors:  Harrison W Gabel; Benyam Kinde; Hume Stroud; Caitlin S Gilbert; David A Harmin; Nathaniel R Kastan; Martin Hemberg; Daniel H Ebert; Michael E Greenberg
Journal:  Nature       Date:  2015-03-11       Impact factor: 49.962
View more
  1 in total

Review 1.  Patient-derived iPSC modeling of rare neurodevelopmental disorders: Molecular pathophysiology and prospective therapies.

Authors:  K R Sabitha; Ashok K Shetty; Dinesh Upadhya
Journal:  Neurosci Biobehav Rev       Date:  2020-12-25       Impact factor: 8.989
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.